Targeting the Cargo Receptor TMED9 as a Therapeutic Strategy Against Brain Tumors
Glioblastoma is one of the most aggressive and lethal forms of brain cancer, with limited therapeutic options and poor patient prognosis. Recent research has identified the TMED family of proteins as key regulators of tumor progression and aggressiveness across multiple cancer types. TMED members ar...
Saved in:
| Main Authors: | Alaa Daoud Sarsour, Sara Kinstlinger, Rephael Nizar, Naama Amos, Narkis Arbeli, Gila Kazimirsky, Irena Bronshtein-Berger, Iris Fried, Ron Unger, Chaya Brodie, Moran Dvela-Levitt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/11/772 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR T cell therapy for central nervous system solid tumors: current progress and future directions
by: Yaroslav Kaminskiy, et al.
Published: (2025-08-01) -
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction
by: Gal Markel, et al.
Published: (2024-11-01) -
Cargo Pour l'enfer : roman /
by: Clavel, Bernard
Published: (1993) -
Landscape of nuclear transport receptor cargo specificity
by: Marie‐Therese Mackmull, et al.
Published: (2017-12-01) -
Defining the Parameters for Sorting of RNA Cargo Into Extracellular Vesicles
by: Ahmed Abdelgawad, et al.
Published: (2025-07-01)